LYCOS RETRIEVER 
Provera: National Women
built 623 days ago
Depo-Provera is one of the most effective and reliable methods of birth control available. In fact, less than one percent of women become pregnant while using Depo-Provera. But it does not protect against sexually transmitted diseases.
Source:
Women who continue to menstruate while on Depo-Provera may have decreased blood flow, which, in turn, reduces the chance of anemia. There may ... be a decrease in menstrual cramps and pain, as well as ovulatory pain.
Source:
There is no proof from clinical studies that shows Depo-Provera increases your risk of acquiring a sexually transmitted disease, or STD. However, Depo-Provera, like other hormonal birth control methods (such as the Pill or the Patch), does not protect you from HIV/AIDS or other STDs. Women using any hormonal contraception, including Depo-Provera, should receive from their healthcare provider clear information and instruction on how they can protect themselves from STDs, such as using a condom consistently and correctly each time they engage in sexual relations.
Source:
Depo Provera may increase your risk of contracting an STD. According to a study in the journal of Sexually Transmitted Diseases, women who took Depo Provera are 3 times more likely to contract chlamydia or gonorrhea as those who use other forms of birth control.
Source:
Fifteen or more years ago, Depo-Provera, which has never gained approval in Canada as a contraceptive, was prescribed for that purpose (through legal loopholes) for teen-aged girls in group homes in Winnipeg and for retarded women in Ontario institutions. "An Ontario inquiry into the drug's use on the retarded in early 1980 found higher-than-normal levels of breast tumours."
Source:
In breast cancer, Provera is mainly used as a treatment for women whose cancer has returned after a period during which it has been successfully controlled with other hormonal drugs, such as tamoxifen. Provera may ... be used in women whose breast cancer has not responded to other hormonal therapies, but whose cancer has receptors for the sex hormone oestrogen on its surface.
Source:
MORE ABOUT
National Women